IXICO CEO Highlights Medidata Collaboration as Key Partnership Example
IXICO PLC reported a 23% revenue increase in its first half of 2026, driven by contract wins, contract extensions, and growth in analytics. CEO Bram Goorden emphasized the importance of the Medidata collaboration as a model for future partnerships and outlined plans for recurring revenue through platform partnerships.
Topics: clinical trials fundraising partnerships revenue growth TechBio strategy